Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 305

1.

French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults.

Hoen B, Bonnet F, Delaugerre C, Delobel P, Goujard C, L'Hénaff M, Persiaux R, Rey D, Rouzioux C, Taburet AM, Morlat P; 2013 French HIV expert group.

J Int AIDS Soc. 2014 Jun 17;17:19034. doi: 10.7448/IAS.17.1.19034. eCollection 2014.

PMID:
24942364
[PubMed - in process]
Free PMC Article
2.

Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.

Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams E.

Cochrane Database Syst Rev. 2014 May 22;5:CD004772. doi: 10.1002/14651858.CD004772.pub4.

PMID:
24852077
[PubMed - in process]
3.

Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE).

Shaffer D, Hughes MD, Sawe F, Bao Y, Moses A, Hogg E, Lockman S, Currier J.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):155-63. doi: 10.1097/QAI.0000000000000131.

PMID:
24562349
[PubMed - indexed for MEDLINE]
4.

Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine: analysis from the AIDS Clinical Trial Group A5208 trial.

Mwafongo A, Nkanaunena K, Zheng Y, Hogg E, Samaneka W, Mulenga L, Siika A, Currier J, Lockman S, Hughes MD, Hosseinipour M; for the AIDS Clinical Trial Group (ACTG) A5208 Team.

AIDS. 2014 Jan 18. [Epub ahead of print]

PMID:
24445367
[PubMed - as supplied by publisher]
5.

Lack of effect of doxycycline on trough concentrations of protease inhibitors or non-nucleoside reverse transcriptase inhibitors in HIV-infected patients.

Abgrall S, Le Bel J, Lele N, Laouénan C, Eychenne N, Mentré F, Peytavin G, Bouchaud O; Vihvo Study Group.

HIV Clin Trials. 2013 Nov-Dec;14(6):313-8. doi: 10.1310/hct1406-313.

PMID:
24334184
[PubMed - indexed for MEDLINE]
6.

HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana.

Shapiro RL, Kitch D, Ogwu A, Hughes MD, Lockman S, Powis K, Souda S, Moffat C, Moyo S, McIntosh K, van Widenfelt E, Zwerski S, Mazhani L, Makhema J, Essex M.

AIDS. 2013 Jul 31;27(12):1911-20.

PMID:
24180000
[PubMed - indexed for MEDLINE]
7.

Clinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antivirals.

Kiang TK, Wilby KJ, Ensom MH.

Clin Pharmacokinet. 2014 Feb;53(2):141-53. doi: 10.1007/s40262-013-0110-5.

PMID:
24158666
[PubMed - in process]
8.

Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients.

Reliquet V, Chirouze C, Allavena C, Muret P, Peytavin G, André-Garnier E, Bettinger D, Ferré V, Hoen B, Raffi F.

Antivir Ther. 2014;19(1):117-23. doi: 10.3851/IMP2691. Epub 2013 Oct 22.

PMID:
24145365
[PubMed - in process]
9.

Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials.

Kawalec P, Kryst J, Mikrut A, Pilc A.

PLoS One. 2013 Oct 7;8(10):e76587. doi: 10.1371/journal.pone.0076587. eCollection 2013.

PMID:
24116123
[PubMed - in process]
Free PMC Article
10.

Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents.

Hashiguchi Y, Hamada A, Shinohara T, Tsuchiya K, Jono H, Saito H.

Biochem Biophys Res Commun. 2013 Sep 20;439(2):221-7. doi: 10.1016/j.bbrc.2013.08.054. Epub 2013 Aug 24.

PMID:
23981805
[PubMed - indexed for MEDLINE]
11.

Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.

Landman R, Koulla-Shiro S, Sow PS, Ngolle M, Diallo MB, Guèye NF, Le Moing V, Eymard-Duvernay S, Benalycherif A, Charpentier C, Peytavin G, Delaporte E, Girard PM; DAYANA Study Group.

Antivir Ther. 2014;19(1):51-9. doi: 10.3851/IMP2675. Epub 2013 Aug 23.

PMID:
23970206
[PubMed - in process]
12.

WHO option B+: early experience of antiretroviral therapy sequencing after cessation of breastfeeding and risk of dermatologic toxicity.

Cohan D, Mwesigwa J, Natureeba P, Aliba Luwedde F, Ades V, Plenty A, Kakuru A, Achan J, Clark T, Osterbauer B, Kamya M, Havlir D.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):e101-3. doi: 10.1097/QAI.0b013e31828011ca. No abstract available.

PMID:
23924639
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Prolonged exposure to lopinavir impairs endothelium-dependent hyperpolarization-mediated relaxation in rat mesenteric arteries.

Yeung YY, Lee SS, Vanhoutte PM, Leung SW.

J Cardiovasc Pharmacol. 2013 Oct;62(4):397-404. doi: 10.1097/FJC.0b013e31829fdd01.

PMID:
23921311
[PubMed - indexed for MEDLINE]
14.

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.

Cruciani M, Mengoli C, Serpelloni G, Parisi SG, Malena M, Bosco O.

Cochrane Database Syst Rev. 2013 Jun 5;6:CD008270. doi: 10.1002/14651858.CD008270.pub2. Review.

PMID:
23740608
[PubMed - indexed for MEDLINE]
15.

Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV-hepatitis C virus coinfected patients.

Vispo E, Fernández-Montero JV, Labarga P, Barreiro P, Soriano V.

AIDS. 2013 Apr 24;27(7):1187-8. doi: 10.1097/QAD.0b013e32835cb815.

PMID:
23739226
[PubMed - indexed for MEDLINE]
16.

Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.

Pombo M, Olalla J, Del Arco A, De La Torre J, Urdiales D, Aguilar A, Prada JL, García-Alegría J, Ruiz-Mateas F.

Eur J Intern Med. 2013 Sep;24(6):558-61. doi: 10.1016/j.ejim.2013.04.007. Epub 2013 May 7.

PMID:
23664642
[PubMed - indexed for MEDLINE]
17.

Talk of HIV cure goes viral.

Holmes D.

Lancet Infect Dis. 2013 Apr;13(4):298-9. Epub 2013 Mar 15. No abstract available.

PMID:
23653929
[PubMed - indexed for MEDLINE]
18.

Drug interactions between antiretrovirals and hormonal contraceptives.

Tseng A, Hills-Nieminen C.

Expert Opin Drug Metab Toxicol. 2013 May;9(5):559-72. doi: 10.1517/17425255.2013.772579. Epub 2013 Feb 21. Review.

PMID:
23425052
[PubMed - indexed for MEDLINE]
19.

Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus.

Shiau S, Arpadi S, Strehlau R, Martens L, Patel F, Coovadia A, Abrams EJ, Kuhn L.

J Pediatr. 2013 Jun;162(6):1138-45, 1145.e1-2. doi: 10.1016/j.jpeds.2012.11.025. Epub 2013 Jan 11.

PMID:
23312691
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors.

da Cunha J, Ferreira Maselli LM, Treitinger A, Monteiro AM, Gidlund M, Maranhão RC, Spada C, Bydlowski SP.

Clin Chem Lab Med. 2013 Feb;51(2):371-8. doi: 10.1515/cclm-2012-0225.

PMID:
23241595
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk